Stelo by Dexcom is a wearable glucose biosensor that brings continuous glucose monitoring into the consumer wellness space, ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors. The company said its Smart Basal ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will ...
G6 Materials Corp., through its subsidiaries, develops, manufactures, and sells proprietary products based on graphene and other materials. It offers air purification materials; general purpose, ...
Synthesis of nanostructured cubic phase SnO 2 thin film and its trace-level sensing of CO gas This study presents a cubic phase SnO 2 thin film gas sensor with ultra-high CO sensitivity and 1 ppb ...
Some alternatives for hormone therapy (HT) may help manage menopause symptoms. Examples include diet and lifestyle changes, supplements, and exercise. Hormone therapy (HT) is generally an effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback